In the CANVAS study, the primary outcome achievement was lower than in the EMPA-REG OUTCOME study and cardiovascular mortality reduction did not reach statistical significance.
← all excerpts
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient.
1
—
—